EGCG for Hepatocellular Carcinoma Chemoprevention

Clinical trial NCT06015022 · RECRUITING

Trial details

NCT number: NCT06015022
Sponsor: University of Texas Southwestern Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cirrhosis, Liver

Start date: 2024-09-01
Primary completion: 2028-08-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.